Small E, Cronquist A (1976) A practical and natural taxonomy for Cannabis. Taxon:405–435
Ogborne AC, Smart RG, Weber T, Birchmore-Timney C (2000) Who is using cannabis as a medicine and why: an exploratory study. J Psychoactive Drugs 32(4):435–443
Article CAS PubMed Google Scholar
Jennings JM, Williams MA, Levy DL, Johnson RM, Eschen CL, Dennis DA (2019) Has self-reported marijuana use changed in patients undergoing total joint arthroplasty after the legalization of marijuana? Clinical orthopaedics and related research. 477(1):95
Coffman KL (2008) The debate about marijuana usage in transplant candidates: recent medical evidence on marijuana health effects. Curr Opin Organ Transplant 13(2):189–195
Deckey DG, Lara NJ, Gulbrandsen MT, Hassebrock JD, Spangehl MJ, Bingham JS (2021) Prevalence of cannabinoid use in patients with hip and knee osteoarthritis, vol 5. JAAOS Global Research & Reviews, 2
Choo EK, Ewing SWF, Lovejoy TI (2016) Opioids out, cannabis in: negotiating the unknowns in patient care for chronic pain. JAMA 316(17):1763–1764
Article PubMed PubMed Central Google Scholar
Heng M, McTague MF, Lucas RC, Harris MB, Vrahas MS, Weaver MJ (2018) Patient perceptions of the use of medical marijuana in the treatment of pain after musculoskeletal trauma: a survey of patients at 2 trauma centers in Massachusetts. J Orthop Trauma 32(1):e25–e30
Jennings JM, McNabb DC, Johnson RM, Brady AC, Kim RH, Dennis DA (2022) Use of cannabis does not decrease opioid consumption in patients who underwent total joint arthroplasty. Arthroplasty Today 15:141–146
Article PubMed PubMed Central Google Scholar
Roche M, Law TY, Sodhi N, Rosas S, Kurowicki J, Disla S et al (2018) Incidence of drug abuse in revision total knee arthroplasty population. J Knee Surg 31(10):928–933
Article PubMed PubMed Central Google Scholar
Moon AS, Smith W, Mullen S, Ponce BA, McGwin G, Shah A et al (2019) Marijuana use and mortality following orthopedic surgical procedures. Substance Abuse 40(3):378–382
Jennings JM, Angerame MR, Eschen CL, Phocas AJ, Dennis DA (2019) Cannabis use does not affect outcomes after total knee arthroplasty. J Arthroplast 34(8):1667–1669
Anand U, Pacchetti B, Anand P, Sodergren MH (2021) Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. Pain Manage 11(4):395–403
Olfson M, Wall MM, Liu S-M, Blanco C (2018) Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry 175(1):47–53
Wilson J, Mills K, Freeman TP, Sunderland M, Visontay R, Marel C (2022) Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction 117(2):284–298
Wu L, Li M, Zeng Y, Si H, Liu Y, Yang P et al (2021) Prevalence and risk factors for prolonged opioid use after total joint arthroplasty: a systematic review, meta-analysis, and meta-regression. Arch Orthop Trauma Surg 141:907–915
Akers J, Aguiar-Ibáñez R, Baba-Akbari Sari A (2009) CRD’s guidance for undertaking reviews in health care. Centre for Reviews and Dissemination (CRD), York
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906
Harrison H, Griffin SJ, Kuhn I, Usher-Smith JA (2020) Software tools to support title and abstract screening for systematic reviews in healthcare: an evaluation. BMC Med Res Methodol 20(1):7. https://doi.org/10.1186/s12874-020-0897-3
Article PubMed PubMed Central Google Scholar
Chandler J, Cumpston M, Li T Cochrane Handbook for Systematic Reviews of Interventions
Haddaway NR, Page MJ, Pritchard CC, McGuinness LAJCsr (2022) PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. 18(2):e1230
Sharma V, Laubach L, Krumme JW, Satpathy J (2022) Cannabis Use among Lower-Extremity Arthroplasty patients does not lead to worse postoperative outcomes. Cureus 14(11):e31964. https://doi.org/10.7759/cureus.31964
Article PubMed PubMed Central Google Scholar
Denduluri SK, Woolson ST, Indelli PF, Mariano ER, Harris AHS, Giori NJ (2021) Cannabinoid and opioid Use among Total Joint Arthroplasty patients: a 6-Year, single-Institution Study. Orthopedics 44(1):e101–e6. https://doi.org/10.3928/01477447-20200928-02
Kirchner GJ, Kim A, Lieber AM, Hines SM, Nikkel LE (2023) Cannabis Use does not increase risk of Perioperative complications following primary total hip arthroplasty: a cohort-matched comparison. Cannabis Cannabinoid Res 8(4):684–690. https://doi.org/10.1089/can.2022.0042
Article CAS PubMed Google Scholar
Hickernell TR, Lakra A, Berg A, Cooper HJ, Geller JA, Shah RP (2018) Should cannabinoids be added to Multimodal Pain regimens after total hip and knee arthroplasty? J Arthroplasty 33(12):3637–3641. https://doi.org/10.1016/j.arth.2018.07.027
Ong CB, Puri S, Lebowitz J, Chiu YF, Della Valle AG, Sideris A et al (2023) Preoperative cannabis use does not increase opioid utilization following primary total hip arthroplasty in a propensity matched analysis. Arch Orthop Trauma Surg 143(6):3629–3635. https://doi.org/10.1007/s00402-022-04619-7
Runner RP, Luu AN, Nassif NA, Scudday TS, Patel JJ, Barnett SL et al (2020) Use of Tetrahydrocannabinol and Cannabidiol products in the Perioperative Period around primary unilateral total hip and knee arthroplasty. J Arthroplasty 35(6s):S138–s43. https://doi.org/10.1016/j.arth.2020.01.077
Zalikha AK, Rahmon D, Mazur M, Hussein IH, El-Othmani MM (2022) Cannabis Use Disorder in the setting of primary total hip arthroplasty: understanding the Epidemiology, demographic characteristics, and Inpatient Postoperative outcomes. J Am Acad Orthop Surg 30(7):321–328. https://doi.org/10.5435/jaaos-d-21-00976
Hegde V, Bracey DN, Pollet AK, Yazdani-Farsad Y, Dennis DA, Jennings JM (2023) Cannabis Use does not affect outcomes after total hip arthroplasty. J Arthroplast 38(9):1808–1811. https://doi.org/10.1016/j.arth.2023.03.040
Hegde V, Bracey DN, Johnson RM, Farsad YY, Dennis DA, Jennings JM (2022) Self-reported Cannabis Use is Associated with a lower rate of Persistent Opioid Use after Total Joint Arthroplasty. Arthroplast Today 17:145–149. https://doi.org/10.1016/j.artd.2022.07.014
Article PubMed PubMed Central Google Scholar
Haffar A, Khan IA, Abdelaal MS, Banerjee S, Sharkey PF, Lonner JH (2022) Topical cannabidiol (CBD) after total knee arthroplasty does not decrease pain or opioid use: a prospective randomized double-blinded placebo-controlled trial. J Arthroplast 37(9):1763–1770
Liu CW, Bhatia A, Buzon-Tan A, Walker S, Ilangomaran D, Kara J et al (2019) Weeding out the problem: the impact of preoperative cannabinoid use on pain in the perioperative period. Anesth Analgesia 129(3):874–881
Weisberg MD, Ng MK, Magruder ML, Vakharia RM, Roche MW, Erez O (2022) The association of cannabis use disorder and perioperative complications after primary total knee arthroplasty. JAAOS-Journal Am Acad Orthop Surg 30(7):313–320
Sambandam S, Mounasamy V, Selvaraj S, Wukich D (2022) Risk of revision surgery and manipulation under anesthesia in patients with cannabis use disorder undergoing total knee arthroplasty. Cureus;14(1)
Vakharia RM, Sodhi N, Anis HK, Ehiorobo JO, Mont MA, Roche MW (2020) Patients who have cannabis use disorder have higher rates of venous thromboemboli, readmission rates, and costs following primary total knee arthroplasty. J Arthroplast 35(4):997–1002
Aleissa MM, Ahern KL, Stern GM (2020) Peri-operative opioid and sedation requirements in patients who use marijuana and are undergoing total knee or total hip arthroplasty: a retrospective study. J Clin Anesth 66:109953
Haffar A, Khan IA, Abdelaal MS, Banerjee S, Sharkey PF (2022) Topical cannabidiol (CBD) after total knee arthroplasty does not decrease pain or opioid use: a prospective randomized double-blinded placebo-controlled trial. 37(9):1763–1770Lonner JHJTJoa
Yu JS, Premkumar A, Liu S, Sculco P (2021) Rates of self-directed perioperative cannabidiol use in patients undergoing total hip or knee arthroplasty. Pain Manage 11(6):655–660
Sambandam S, Mounasamy V, Selvaraj S, Wukich DJC (2022) Risk of revision surgery and manipulation under anesthesia in patients with cannabis use disorder undergoing total knee arthroplasty;14(1)
Vakharia RM, Sodhi N, Anis HK, Ehiorobo JO, Mont MA (2020) Patients who have cannabis use disorder have higher rates of venous thromboemboli, readmission rates, and costs following primary total knee arthroplasty. 35(4):997–1002Roche MWJTJoA
Weisberg MD, Ng MK, Magruder ML, Vakharia RM, Roche MW, Erez OJJ-JAAOS (2022) The association of cannabis use disorder and perioperative complications after primary total knee arthroplasty. 30(7):313–320
Zalikha AK, Rahmon D, Mazur M, Hussein IH, El-Othmani MMJJ-JAAOS (2022) Cannabis use disorder in the setting of primary total hip arthroplasty: understanding the epidemiology, demographic characteristics, and inpatient postoperative outcomes. 30(7):321–328
Denduluri SK, Woolson ST, Indelli PF, Mariano ER, Harris AH, Giori NJJO (2021) Cannabinoid and opioid use among total joint arthroplasty patients: a 6-year, single-institution study. 44(1):e101–e6
Turan OA, Rullan PJ, Pasqualini I, Pumo TJ, Surace PA, Murray TG et al (2024) Cannabis Use following total joint arthroplasty is Associated with increased risks? A Meta-analysis. J Arthroplasty 39(2):533–40e6. https://doi.org/10.1016/j.arth.2023.07.008
Oster B, Hameed D, Bains SS, Delanois RE, Johnson AJ, Nace J et al (2023) Tobacco and Cannabis Use have a Synergistic Association on Infection Risk Following Total Knee Arthroplasty. J Arthroplasty 38(10):2137–2141.
留言 (0)